BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19319121)

  • 1. Predictive factors of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration in patients with gastric varices.
    Elsamman MK; Fujiwara Y; Kameda N; Okazaki H; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Oshitani N; Arafa UA; El-Sayed AA; Nakamura K; Arakawa T
    Am J Gastroenterol; 2009 Sep; 104(9):2214-21. PubMed ID: 19319121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients.
    Ninoi T; Nishida N; Kaminou T; Sakai Y; Kitayama T; Hamuro M; Yamada R; Nakamura K; Arakawa T; Inoue Y
    AJR Am J Roentgenol; 2005 Apr; 184(4):1340-6. PubMed ID: 15788621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration.
    Kasuga A; Mizumoto H; Matsutani S; Kobayashi A; Endo T; Ando T; Yukisawa S; Maruyama H; Yokosuka O
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):898-903. PubMed ID: 20461439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience.
    Akahoshi T; Hashizume M; Tomikawa M; Kawanaka H; Yamaguchi S; Konishi K; Kinjo N; Maehara Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1702-9. PubMed ID: 18713295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices: therapeutic results and problems].
    Kiyosue H; Matsumoto S; Onishi R; Okahara M; Hori Y; Yamada Y; Dono S; Mori H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jan; 59(1):12-9. PubMed ID: 10067311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices.
    Imai Y; Nakazawa M; Ando S; Sugawara K; Mochida S
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1844-1850. PubMed ID: 27003222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in the treatment of gastric varices in cirrhotic patients with gastrorenal shunt].
    Baik GH; Kim DJ; Lee HG; Min SK; Kong SJ; Kim JB; Lee JY; Hahn TH; Baek IH; Kim JH; Kim BS; Hwang WC
    Korean J Gastroenterol; 2004 Mar; 43(3):196-203. PubMed ID: 15034290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.
    Fukuda T; Hirota S; Sugimura K
    J Vasc Interv Radiol; 2001 Mar; 12(3):327-36. PubMed ID: 11287510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration.
    Naeshiro N; Aikata H; Kakizawa H; Hyogo H; Kan H; Fujino H; Kobayashi T; Fukuhara T; Honda Y; Ohno A; Miyaki D; Kawaoka T; Tsuge M; Hiraga N; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Awai K; Chayama K
    J Gastroenterol Hepatol; 2014 May; 29(5):1035-42. PubMed ID: 24372807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Balloon-occluded Retrograde Transvenous Obliteration for Gastric Varices.
    Jogo A; Nishida N; Yamamoto A; Kageyama K; Nakano M; Sohgawa E; Hamamoto S; Hamuro M; Miki Y
    Intern Med; 2019 Aug; 58(16):2291-2297. PubMed ID: 31118379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with aggravation of esophageal varices after B-RTO for gastric varices.
    Jogo A; Nishida N; Yamamoto A; Matsui H; Takeshita T; Sakai Y; Matsuoka T; Nakamura K; Miki Y
    Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1243-50. PubMed ID: 24322305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration.
    Hiraga N; Aikata H; Takaki S; Kodama H; Shirakawa H; Imamura M; Kawakami Y; Takahashi S; Toyota N; Ito K; Tanaka S; Kitamoto M; Chayama K
    J Gastroenterol; 2007 Aug; 42(8):663-72. PubMed ID: 17701130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to thrombosis of gastric varix during balloon-occluded retrograde transvenous obliteration.
    Yoshimatsu R; Yamagami T; Miura H; Hashiba M
    Acta Radiol; 2015 May; 56(5):592-7. PubMed ID: 24812417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
    Kumamoto M; Toyonaga A; Inoue H; Miyakoda K; Morita Y; Emori K; Sakamoto Y; Oho K; Sata M
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1129-35. PubMed ID: 20594229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices.
    Matsumoto A; Hamamoto N; Nomura T; Hongou Y; Arisaka Y; Morikawa H; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Mar; 94(3):643-9. PubMed ID: 10086645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis.
    Takuma Y; Nouso K; Makino Y; Saito S; Shiratori Y
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1245-52. PubMed ID: 16361051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
    Miyamoto Y; Oho K; Kumamoto M; Toyonaga A; Sata M
    J Gastroenterol Hepatol; 2003 Aug; 18(8):934-42. PubMed ID: 12859723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: a prospective, randomized, comparative clinical trial.
    Shiba M; Higuchi K; Nakamura K; Itani A; Kuga T; Okazaki H; Fujiwara Y; Arakawa T
    Gastrointest Endosc; 2002 Oct; 56(4):522-8. PubMed ID: 12297768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for rebleeding and prognostic factors for postoperative survival in patients with balloon-occluded retrograde transvenous obliteration of acute gastric variceal rupture.
    Kageyama K; Nishida N; Yamamoto A; Jogo A; Hamamoto S; Matsui H; Tokunaga M; Miki Y
    Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1235-42. PubMed ID: 24402642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a new coaxial balloon catheter system for balloon-occluded retrograde transvenous obliteration (B-RTO).
    Tanoue S; Kiyosue H; Matsumoto S; Hori Y; Okahara M; Kashiwagi J; Mori H
    Cardiovasc Intervent Radiol; 2006; 29(6):991-6. PubMed ID: 16736100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.